Skip to content
Preprint · CC-BY via OpenAlex

The Optimal Treatments for Type 2 Diabetes from The Perspective of Anti-Aging Medicine

Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Hisayuki Katsuyama

Preprints.org · 2025

Abstract

Aging is a complex biological process that involves a gradual decline in the human body's structure and function and increases the risks of aging-related diseases such as Alzheimer's disease (AD) and type 2 diabetes. Type 2 diabetes accelerates all clinical manifestations of aging. Metabolic disorders in type 2 diabetes are unfavorably associ-ated with all telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition) such as inflammation and mitochondrial dysfunction(definition). AMP-activated protein kinase (AMPK) and the mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) com-plex 1 (mTORC1) are key players in cellular metabolism. AMPK activation and mTORC1 inhibition improve all hallmarks of aging. Furthermore, AMPK activation and mTORC1 inhibition are favorably associated with diabetic complications such as diabetic neuropathy, retinopathy, nephropathy and cardiovascular diseases and AD. Nutrition such as resveratrol and astaxanthin have AMPK activating and mTORC1 in-hibitory effects and improve metabolic abnormalities in type 2 diabetes. Metformin, sodium-glucose co-transporter-2 inhibitors, glucagon-like peptide 1 receptor agonists (GLP-1RAs), and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs, have been reported to have AMPK activating and mTORC1 inhibitory effects. The therapeutic interventions that activate AMPK and inhibit mTORC1 may be optimal treatments for type 2 diabetes from the perspective of anti-aging medicine.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.20944/preprints202508.0997.v1
Canonical
link ↗
Fetched
2026-11-05 MST

Cite this

APA
Yanai, H., Adachi, H., Hakoshima, M., &amp; Katsuyama, H. (2025). The Optimal Treatments for Type 2 Diabetes from The Perspective of Anti-Aging Medicine. <em>Preprints.org</em>. https://doi.org/10.20944/preprints202508.0997.v1
Vancouver
Yanai H, Adachi H, Hakoshima M, Katsuyama H. The Optimal Treatments for Type 2 Diabetes from The Perspective of Anti-Aging Medicine. Preprints.org. 2025. doi:10.20944/preprints202508.0997.v1.
BibTeX
@unpublished{hidekatsu2025TheOpt, title = {The Optimal Treatments for Type 2 Diabetes from The Perspective of Anti-Aging Medicine}, author = {Hidekatsu Yanai and Hiroki Adachi and Mariko Hakoshima and Hisayuki Katsuyama}, journal = {Preprints.org}, year = {2025}, doi = {10.20944/preprints202508.0997.v1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings